MedTrace Logo

Culturally Adapted CMAP Plus LTP for Refugee Mothers with History of Self-harm in Pakistan

NCT05171192 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-12-10

No results posted yet for this study

Summary

Objectives:

* To asses the feasibility and acceptability of a culturally adapted manual assisted brief psychological intervention (CMAP) plus Learning through Play (LTP) for refugee mothers with history of self-harm having children 0-33 months. (Integrated intervention called CMAP Plus)
* To assess if CMAP Plus will reduce the repetition of self-harm in refugee mothers having children aged between 0-33 months.
* To determine if the intervention improves infant development and maternal attachment.
* To explore participants experiences with the intervention.

Study design and setting:

This will be a feasibility cluster randomized control trial (cRCT) of culturally adapted CMAP Plus LTP intervention with refugee mothers from Quetta and Peshawar, Pakistan.

Sample size:

We aim to recruit a sample of 80 refugee mothers in the study.

Conditions

  • Self-harm
  • Child Development

Interventions

BEHAVIORAL

CMAP Plus LTP

The LTP Plus CMAP intervention will be delivered for a period of 12 weeks, including 8 weekly sessions and 2 sessions fortnightly. First 6 sessions will be for a duration of 60-90 minutes and remaining 4 sessions will take approximately 50-60 minutes. All sessions will be delivered by female therapists trained in CMAP and LTP intervention.

Sponsors & Collaborators

  • University of Manchester

    collaborator OTHER

  • Pakistan Institute of Living and Learning

    lead OTHER

Principal Investigators

  • Nusrat Husain · University of Manchester

  • Nasim Chahudhry · Pakistan Institute of Living and Learning

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2023-12-15
Completion
2024-12-01

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05171192 on ClinicalTrials.gov